WebAug 8, 2024 · Conference Call and Webcast Information. CinCor management will hold a conference call and webcast today at 8:30 AM Eastern Time to provide an update on the BrigHtn Phase 2 trial. The dial-in ... WebJan 9, 2024 · 6 analysts have issued twelve-month price objectives for CinCor Pharma's stock. Their CINC share price forecasts range from $30.00 to $67.00. On average, they expect the company's stock price to reach $46.67 in the next year. This suggests a possible upside of 60.6% from the stock's current price. View analysts price targets for CINC or …
CinCor Pharma to be Acquired by AstraZeneca - Yahoo Finance
WebNov 28, 2024 · Cincor Pharma drug baxdrostat failed its Phase 2 test, falling short of the goal of reducing blood pressure in patients with uncontrolled hypertension. But results in a subgroup of patients showed ... WebApr 19, 2024 · WALTHAM, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) today announced its participation in the Jefferies Biotech on the Bay Summit taking place April 26-27 in Miami ... flyger fabricators \\u0026 engineers
AstraZeneca boosts heart, kidney business with $1.8 billion CinCor …
WebJan 9, 2024 · CinCor stockholders holding approximately 44.8% of CinCor common stock have entered into a tender and support agreement with AstraZeneca, pursuant to which … WebJun 1, 2024 · figHTN-CKD is CinCor’s fourth ongoing Phase 2 clinical trial evaluating baxdrostat (CIN-107) Initial topline data for figHTN-CKD expected in 2H 2024 WALTHAM, Mass., June 01, 2024 (GLOBE NEWSWIRE ... WebSep 14, 2024 · Insiders who bought CinCor Pharma, Inc. ( NASDAQ:CINC ) in the last 12 months may probably not pay attention to the... flyger and co hairdressers